The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

On August 22, Moderna announced that FDA approved ... On the same day, Pfizer and BioNTech also announced that they received approval for their sBLA for an updated composition of their Omicron ...

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

The company's vaccine consists of an mRNA sequence encoding a stabilized prefusion F glycoprotein.

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans ...

These vaccines are now available to adults 60 and older. In terms of dosage, the CDC recommends a single dose for individuals over 75.

The Hawaii Department of Health is recommending residents get updated flu and COVID-19 vaccines that are now available.

The vaccines are free with most private insurance plans, Medicare and Medicaid. Those without insurance will have to pay ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, ...